Restoration of SOCS3 suppresses human lung adenocarcinoma cell growth by downregulating activation of Erk1/2, Akt apart from STAT3

Cell Biology International

Volumn 33, Issue 9, 2009, Pages 995-1001

  Yu, Zu bin ^a   Bai, Li ^a   Qian, Pin ^a   Xiao, Yin bin ^a   Wang, Guan song ^a   Qian, Gui sheng ^a   Bai, Chun xue ^b   Min, Jia xin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Akt; Erk1 2; Lung carcinoma; SOCS; STAT3

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL ACTIVITY; CELL ASSAY; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOSS; GENE REPRESSION; GENE SILENCING; GENETIC REGULATION; GROWTH INHIBITION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUNG ADENOCARCINOMA; MALE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFECTION;

EID: 68949199430     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2009.06.002     Document Type: Article

References (25)

1. Auernhammer C.J., Bousquet C., and Melmed S. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A 96 (1999) 6964-6969
2. Bai L., Zhu R., Chen Z., Gao L., Zhang X., Wang X., et al. Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells. Biochem Pharmacol 71 (2006) 1265-1271
3. Cacalano N.A., Sanden D., and Johnston J.A. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat Cell Biol 3 (2001) 460-465
4. Emanuelli B., Peraldi P., Filloux C., Sawka-Verhelle D., Hilton D., and Van Obberghen E. SOCS-3 is an I nsulin-induced negative regulator of insulin signaling. J Biol Chem 275 (2000) 15985-15991
5. Friday B.B., and Adjei A.A. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin Cancer Res 14 (2008) 342-346
6. Frobøse H., Rønn S.G., Heding P.E., Mendoza H., Cohen P., Mandrup-Poulsen T., et al. Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol Endocrinol 20 (2006) 1587-1596
7. He B., You L., Uematsu K., Zang K., Xu Z., Lee A.Y., et al. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci U S A 100 (2003) 14133-14138
8. Hilton D.J. Negative regulators of cytokine signal transduction. Cell Mol Life Sci 55 (1999) 1568-1577
9. Hirsch F.R., Scagliotti G.V., Langer C.J., Varella-Garcia M., and Franklin W.A. Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies. Lung Cancer 41 (2003) S29-S42
10. Isomoto H., Mott J.L., Kobayashi S., Werneburg N.W., Bronk S.F., Haan S., et al. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing. Gastroenterology 132 (2007) 384-396
11. Kile B.T., Nicola N.A., and Alexander W.S. Negative regulators of cytokine signaling. Int J Hematol 73 (2000) 292-297
12. Kim J.H., Kim J.E., Liu H.Y., Cao W., and Chen J. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. J Biol Chem 283 (2008) 708-715
13. Kinjyo I., Ohishi M., Shouda T., Kobayashi T., and Yoshimura A. Positive and negative roles of IL-6, STAT3, and SOCS3 in inflammatory arthritis. Adv Exp Med Biol 602 (2007) 113-124
14. Krebs D.L., and Hilton D.J. SOCS protein: negative regulators of cytokine signaling. Stem Cells 19 (2001) 378-387
15. Lu Y., Fukuyama S., Yoshida R., Kobayashi T., Saeki K., Shiraishi H., et al. Loss of SOCS3 gene expression converts STAT3 function from anti-apoptotic to pro-apoptotic. J Biol Chem 281 (2006) 36683-36690
16. Nicholson S.E., De Souza D., Fabri L.J., Corbin J., Willson T.A., Zhang J.G., et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci U S A 97 (2000) 6493-6498
17. Ogata H., Kobayashi T., Chinen T., Takaki H., Sanada T., Minoda Y., et al. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 131 (2006) 179-193
18. Ogata Y., Osaki T., Naka T., Iwahori K., Furukawa M., Nagatomo I., et al. Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation. Neoplasia 8 (2006) 817-825
19. Riehle K.J., Campbell J.S., McMahan R.S., Johnson M.M., Beyer R.P., Bammler T.K., et al. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. J Exp Med 205 (2008) 91-103
20. Shouda T., Hiraoka K., Komiya S., Hamada T., Zenmyo M., Iwasaki H., et al. Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells. Cancer Lett 231 (2006) 176-184
21. Tokita T., Maesawa C., Kimura T., Kotani K., Takahashi K., Akasaka T., et al. Methylation status of the SOCS3 gene in human malignant melanomas. Int J Oncol 30 (2007) 689-694
22. Tokunaga E., Oki E., Egashira A., Sadanaga N., Morita M., Kakeji Y., et al. Deregulation of the Akt pathway in human cancer. Curr Cancer Drug Targets 8 (2008) 27-36
23. Tortorella C., Simone O., Piazzolla G., Stella I., Cappiello V., and Antonaci S. Role of phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways in granulocyte macrophage-colony-stimulating factor failure to delay fas-induced neutrophil apoptosis in elderly humans. J Gerontol A Biol Sci Med Sci 61 (2006) 1111-1118
24. Weber A., Hengge U.R., Bardenheuer W., Tischoff I., Sommerer F., Markwarth A., et al. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 24 (2005) 6699-6708
25. Xia L., Wang L., Chung A.S., Ivanov S.S., Ling M.Y., Dragoi A.M., et al. Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation. J Biol Chem 277 (2002) 30716-30723